Chunyan Dong

4.5k total citations · 1 hit paper
111 papers, 3.5k citations indexed

About

Chunyan Dong is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Chunyan Dong has authored 111 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 44 papers in Biomedical Engineering and 26 papers in Oncology. Recurrent topics in Chunyan Dong's work include Nanoplatforms for cancer theranostics (39 papers), Nanoparticle-Based Drug Delivery (22 papers) and RNA Interference and Gene Delivery (12 papers). Chunyan Dong is often cited by papers focused on Nanoplatforms for cancer theranostics (39 papers), Nanoparticle-Based Drug Delivery (22 papers) and RNA Interference and Gene Delivery (12 papers). Chunyan Dong collaborates with scholars based in China, United States and Switzerland. Chunyan Dong's co-authors include Shuo Shi, Yonglin Lu, Xiaochun Hu, Yun Lin, Jingxian Yang, Chunhui Wang, Yongyong Li, Zhounan Zhu, Lulu Zhou and Zhiwang Song and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Chunyan Dong

106 papers receiving 3.5k citations

Hit Papers

Therapeutic cancer vaccines: advancements, challenges and... 2023 2026 2024 2025 2023 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunyan Dong China 33 1.6k 1.3k 846 773 627 111 3.5k
Chunhui Wu China 36 1.7k 1.1× 1.4k 1.1× 994 1.2× 789 1.0× 319 0.5× 113 3.8k
Shuang Wang China 36 1.7k 1.0× 1.9k 1.5× 573 0.7× 759 1.0× 722 1.2× 100 4.1k
Yourong Duan China 38 1.6k 1.0× 1.5k 1.2× 1.3k 1.5× 454 0.6× 393 0.6× 130 3.8k
Liping Zhong China 31 1.3k 0.8× 1.7k 1.3× 446 0.5× 658 0.9× 456 0.7× 114 3.9k
Xuexiang Han China 42 2.1k 1.3× 2.6k 2.0× 1.2k 1.4× 1.0k 1.3× 840 1.3× 64 5.4k
Chun Gwon Park South Korea 32 1.3k 0.8× 1.4k 1.1× 933 1.1× 345 0.4× 804 1.3× 126 3.9k
Keman Cheng China 31 2.2k 1.4× 1.7k 1.3× 860 1.0× 485 0.6× 1.2k 1.9× 52 4.3k
Hong Pan China 34 2.1k 1.3× 1.5k 1.2× 858 1.0× 377 0.5× 1.0k 1.6× 72 3.7k
Jin‐Xuan Fan China 31 2.9k 1.8× 1.4k 1.1× 869 1.0× 1.3k 1.7× 406 0.6× 80 4.5k
Lin Hou China 36 2.4k 1.5× 925 0.7× 1.2k 1.4× 1.1k 1.4× 918 1.5× 90 4.2k

Countries citing papers authored by Chunyan Dong

Since Specialization
Citations

This map shows the geographic impact of Chunyan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyan Dong more than expected).

Fields of papers citing papers by Chunyan Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyan Dong. The network helps show where Chunyan Dong may publish in the future.

Co-authorship network of co-authors of Chunyan Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyan Dong. A scholar is included among the top collaborators of Chunyan Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyan Dong. Chunyan Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunhui, Mengyao Chen, Ruihao Li, et al.. (2025). Reducing the availability of endogenous copper and glucose for cascade starvation therapy and chemodynamic therapy. Materials Today Bio. 32. 101702–101702. 7 indexed citations
3.
Dong, Chunyan, et al.. (2024). Detection of effective prestressing of 1860-grade strands based on the microporous method. Scientific Reports. 14(1). 26084–26084.
4.
Dong, Chunyan, et al.. (2023). Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism. SHILAP Revista de lepidopterología. 4(6). e416–e416. 14 indexed citations
5.
Hu, Xiaochun, Guanghua Wang, Kang Fang, et al.. (2023). The construction of Fe-porphyrin nanozymes with peroxidase-like activity for colorimetric detection of glucose. Analytical Biochemistry. 675. 115224–115224. 6 indexed citations
6.
Fang, Kang, Yanting Sun, Jingxian Yang, et al.. (2023). A Dual Stimuli‐Responsive Nanoplatform Loaded PtIV‐Triptolide Prodrug for Achieving Synergistic Therapy toward Breast Cancer. Advanced Healthcare Materials. 12(28). e2301328–e2301328. 15 indexed citations
7.
Hu, Xiaochun, Wenrong Zhao, Ruihao Li, et al.. (2023). A cascade nanoplatform for the regulation of the tumor microenvironment and combined cancer therapy. Nanoscale. 15(40). 16314–16322. 7 indexed citations
8.
Wang, Chunhui, et al.. (2023). Cu-related agents for cancer therapies. Coordination Chemistry Reviews. 487. 215156–215156. 44 indexed citations
9.
Fan, Ting, Mingna Zhang, Jingxian Yang, et al.. (2023). Therapeutic cancer vaccines: advancements, challenges and prospects. Signal Transduction and Targeted Therapy. 8(1). 450–450. 278 indexed citations breakdown →
10.
Feng, Lei, Dan Zhang, Ruihao Li, et al.. (2023). Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy. Stem Cells International. 2023. 1–14. 5 indexed citations
11.
12.
Li, Ruihao, Xiaochun Hu, Fangjian Shang, et al.. (2022). Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals. Acta Biomaterialia. 148. 218–229. 38 indexed citations
13.
Zhao, Xiaosu, et al.. (2021). MiR-155-5p affects Wilms’ tumor cell proliferation and apoptosis via targeting CREB1. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Hu, Xiaochun, Yonglin Lu, Wenrong Zhao, et al.. (2021). A PDA-DTC/Cu–MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment. Chemical Communications. 57(34). 4158–4161. 20 indexed citations
15.
Sun, Yanting, Yuling Li, Shuo Shi, & Chunyan Dong. (2021). Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems. Molecules. 26(9). 2703–2703. 14 indexed citations
16.
Chen, Mengyao, Chunyan Dong, & Shuo Shi. (2021). Nanoparticle‐Mediated siRNA Delivery and Multifunctional Modification Strategies for Effective Cancer Therapy. Advanced Materials Technologies. 6(10). 18 indexed citations
17.
Song, Zhiwang, Xia Zhang, Yun Lin, et al.. (2019). LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. Journal of Cellular and Molecular Medicine. 23(11). 7554–7565. 54 indexed citations
18.
Feng, Chan, Kun Wang, Yun Lin, et al.. (2018). Extracellular retention of a cyclopamine nanoformulation leveraging larger size and more negative charge for improved breast cancer treatment. Journal of Materials Chemistry. 1 indexed citations
19.
Dong, Chunyan, et al.. (2016). Modulation of influenza A virus replication by microRNA‐9 through targeting MCPIP1. Journal of Medical Virology. 89(1). 41–48. 31 indexed citations
20.
Shi, Ning, Ying Li, Chunyan Dong, et al.. (2016). Quantitative Proteome Profiling of Street Rabies Virus-Infected Mouse Hippocampal Synaptosomes. Current Microbiology. 73(3). 301–311. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026